These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17665438)

  • 1. Antiresorptive agents and osteoarthritis: more than a bone to pick?
    Abramson SB; Honig S
    Arthritis Rheum; 2007 Aug; 56(8):2469-73. PubMed ID: 17665438
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for the potential use of calcitonin in osteoarthritis.
    Manicourt DH; Devogelaer JP; Azria M; Silverman S
    J Musculoskelet Neuronal Interact; 2005; 5(3):285-93. PubMed ID: 16172519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?
    Karsdal MA; Tanko LB; Riis BJ; Sondergard BC; Henriksen K; Altman RD; Qvist P; Christiansen C
    Osteoarthritis Cartilage; 2006 Jul; 14(7):617-24. PubMed ID: 16698291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcitonin].
    Nakano T
    Clin Calcium; 2008 Oct; 18(10):1460-8. PubMed ID: 18830043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
    Karsdal MA; Bay-Jensen AC; Lories RJ; Abramson S; Spector T; Pastoureau P; Christiansen C; Attur M; Henriksen K; Goldring SR; Kraus V
    Ann Rheum Dis; 2014 Feb; 73(2):336-48. PubMed ID: 24285494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 8. Should subchondral bone turnover be targeted when treating osteoarthritis?
    Karsdal MA; Leeming DJ; Dam EB; Henriksen K; Alexandersen P; Pastoureau P; Altman RD; Christiansen C
    Osteoarthritis Cartilage; 2008 Jun; 16(6):638-46. PubMed ID: 18362080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin, bone-active isoflavones and vitamin D metabolites.
    Gennari C
    Osteoporos Int; 1999; 9 Suppl 2():S81-90. PubMed ID: 10525730
    [No Abstract]   [Full Text] [Related]  

  • 10. Cartilage repair and conservation in osteoarthritis. A brief review of some experimental approaches to chondroprotection.
    Howell DS; Altman RD
    Rheum Dis Clin North Am; 1993 Aug; 19(3):713-24. PubMed ID: 8210583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A more active role for gynecologists in the prevention of postmenopausal osteoporosis.
    Ylikorkala O
    Gynecol Endocrinol; 2008 Jun; 24(6):293-4. PubMed ID: 18584406
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of osteoporosis in octogenarians].
    Pepersack T
    Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis.
    Herrero-Beaumont G; Roman-Blas JA; Largo R; Berenbaum F; Castañeda S
    Ann Rheum Dis; 2011 Sep; 70(9):1523-5. PubMed ID: 21742638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The futility of current approaches to chondroprotection - a different perspective: comment on the article by Felson and Kim.
    Brandt KD; Radin EL; Dieppe PA; van de Putte L
    Arthritis Rheum; 2007 Nov; 56(11):3873-4; author reply 3874. PubMed ID: 17968876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The futility of current approaches to chondroprotection.
    Felson DT; Kim YJ
    Arthritis Rheum; 2007 May; 56(5):1378-83. PubMed ID: 17469094
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of bone in osteoarthritis pathogenesis.
    Goldring SR
    Rheum Dis Clin North Am; 2008 Aug; 34(3):561-71. PubMed ID: 18687272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinociceptive effect of calcitonin].
    Takayama B; Kikuchi S; Konno S; Sekiguchi M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():391-5. PubMed ID: 18161138
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent insights into mechanisms for analgesic effect by calcitonin].
    Ito A; Furue H; Yoshimura M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():386-90. PubMed ID: 18161137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.